These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32949496)

  • 1. Dual Purpose Vectors for Rare Neurological Diseases.
    Bigger BW
    Mol Ther; 2020 Oct; 28(10):2104-2105. PubMed ID: 32949496
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene therapies advance towards finish line.
    Mullard A
    Nat Rev Drug Discov; 2011 Sep; 10(10):719-20. PubMed ID: 21959273
    [No Abstract]   [Full Text] [Related]  

  • 3. Designer viruses could be the secret to cheaper and better gene therapy.
    Savage N
    Nature; 2018 Dec; 564(7735):S18-S19. PubMed ID: 30542181
    [No Abstract]   [Full Text] [Related]  

  • 4. The Platform Vector Gene Therapies Project: Increasing the Efficiency of Adeno-Associated Virus Gene Therapy Clinical Trial Startup.
    Brooks PJ; Ottinger EA; Portero D; Lomash RM; Alimardanov A; Terse P; Xu X; Chandler RJ; Geist Hauserman J; Esposito E; Bönnemann CG; Venditti CP; Austin CP; Pariser A; Lo DC
    Hum Gene Ther; 2020 Oct; 31(19-20):1034-1042. PubMed ID: 32993373
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gene therapy and rare diseases].
    Cohen-Haguenauer O
    Rev Med Interne; 2011 Dec; 32 Suppl 2():S210-2. PubMed ID: 22037347
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy: Industrial strength.
    Bender E
    Nature; 2016 Sep; 537(7619):S57-9. PubMed ID: 27602741
    [No Abstract]   [Full Text] [Related]  

  • 7. A patient and family perspective on gene therapy for rare diseases.
    Kent A; Oosterwijk C
    J Gene Med; 2007 Oct; 9(10):922-3. PubMed ID: 17880044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The consortium project to treat RPE65 deficiency in humans.
    Hauswirth WW
    Retina; 2005 Dec; 25(8 Suppl):S60. PubMed ID: 16374340
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ophthalmogenetics: Rare Diseases - A Challenge for Diagnostic and Treatment].
    Rudolph G
    Klin Monbl Augenheilkd; 2016 Mar; 232(3):242. PubMed ID: 27011027
    [No Abstract]   [Full Text] [Related]  

  • 10. Glybera and the future of gene therapy in the European Union.
    Miller N
    Nat Rev Drug Discov; 2012 May; 11(5):419. PubMed ID: 22679644
    [No Abstract]   [Full Text] [Related]  

  • 11. Bumps in the Road for Commercial Gene Therapy for Rare Diseases.
    Ylä-Herttuala S
    Mol Ther; 2017 Oct; 25(10):2225. PubMed ID: 28939088
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene therapy of inherited diseases.
    Fischer A; Cavazzana-Calvo M
    Lancet; 2008 Jun; 371(9629):2044-7. PubMed ID: 18555917
    [No Abstract]   [Full Text] [Related]  

  • 13. 2016 Curt Stern Award Address: From Rare to Common Diseases: Translating Genetic Discovery to Therapy.
    Lee B
    Am J Hum Genet; 2017 Mar; 100(3):397-400. PubMed ID: 28257687
    [No Abstract]   [Full Text] [Related]  

  • 14. Access to gene therapy for rare diseases when commercialization is not fit for purpose.
    Fox T; Bueren J; Candotti F; Fischer A; Aiuti A; Lankester A; ; Booth C
    Nat Med; 2023 Mar; 29(3):518-519. PubMed ID: 36782029
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetics and Gene Therapy of Anderson-Fabry Disease.
    Simonetta I; Tuttolomondo A; Di Chiara T; Miceli S; Vogiatzis D; Corpora F; Pinto A
    Curr Gene Ther; 2018; 18(2):96-106. PubMed ID: 29618309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Era for Rare Genetic Diseases: Messenger RNA Therapy.
    Martini PGV; Guey LT
    Hum Gene Ther; 2019 Oct; 30(10):1180-1189. PubMed ID: 31179759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics and Gene Therapy in Hunter Disease.
    Sestito S; Falvo F; Scozzafava C; Apa R; Pensabene L; Bonapace G; Moricca MT; Concolino D
    Curr Gene Ther; 2018; 18(2):90-95. PubMed ID: 29618310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ensuring a future for gene therapy for rare diseases.
    Aiuti A; Pasinelli F; Naldini L
    Nat Med; 2022 Oct; 28(10):1985-1988. PubMed ID: 35970921
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rare diseases and the CRISPR technology...].
    Carayon P; Cler E; By Y
    Ann Biol Clin (Paris); 2016; 74(2):125-9. PubMed ID: 27029719
    [No Abstract]   [Full Text] [Related]  

  • 20. [The time has come of a therapeutic (re)positioning of the ultra-rare diseases].
    Martinat C; Peschanski M
    Med Sci (Paris); 2018 Dec; 34(12):1019-1021. PubMed ID: 30623755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.